Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL.
Company profile
Ticker
ADLS
Exchange
CEO
Michael T. Flavin
Employees
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
300296543
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
28 Jul 17
8-K
Other Events
12 May 11
8-K
Unregistered Sales of Equity Securities
3 May 11
424B1
Prospectus with pricing info
22 Apr 11
8-K
Entry into a Material Definitive Agreement
22 Apr 11
EFFECT
Notice of effectiveness
20 Apr 11
DEF 14A
Definitive proxy
13 Apr 11
8-K
Changes in Registrant's Certifying Accountant
8 Apr 11
POS AM
Prospectus update (post-effective amendment)
8 Apr 11
PRER14A
Preliminary revised proxy
7 Apr 11
Latest ownership filings